| St. Jude Medical Announces European Approval and Launch of the EnligHTN Renal ... - SunHerald.com |
|
|
SunHerald.com PARIS -- St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced CE Mark Approval and launch of its EnligHTN™ renal denervation system during EuroPCR. Renal denervation is a specialized ablation procedure that has been |